Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
boston blog main
new york blog main
boston
boston top stories
clinical trials
national top stories
new york top stories
abcellera
alirocumab
alnylam pharmaceuticals
amgen
antibodies
azacitidine
beta-thalassemia
cancer
codiak biosciences
coronavirus
covid-19
cutaneous t-cell lymphoma
dacogen
deals
decitabine
dna
drug discovery
drugs
eli lilly
epigenetics
epizyme
evercore isi
evolocumab
exosome
farydak
flagship pioneering
fulcrum therapeutics
heart attack
inclisiran
insulated genomic domains
What
based
4
×
medicines
4
×
new
biotech
abcellera
abcellera’s
aims
alnylam
antibodies
antibody
approach
begin
biologics
biosciences
bio’s
brings
bubbles
called
cells
cholesterol
class
clinical
codiak
coronavirus
data
debuts
developing
drug
drugs
enter
epigenetic
epigenetics
evidence
exosome
exosomes
field
flagship’s
formed
fund
heart
Language
unset
Current search:
xconomy.com
×
based
×
medicines
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
4 years ago
AbCellera’s Coronavirus “Neutralizing” Antibody Leads Enter Screening
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
